Cannabidiol for the treatment of psychosis in Parkinson's disease

被引:1
作者
Zuardi, A. W. [1 ]
Crippa, J. A. S. [1 ]
Hallak, J. E. C. [1 ]
Pinto, J. P. [1 ]
Chagas, M. H. N. [1 ]
Rodrigues, G. G. R. [1 ]
Dursun, S. M. [2 ]
Tumas, V. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil
[2] Univ Manchester, Neurosci & Psychiat Unit, Manchester, Lancs, England
关键词
D O I
10.1016/S0924-977X(08)70608-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S417 / S418
页数:2
相关论文
共 3 条
[1]   Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:: Relevance to Parkinson's disease [J].
Lastres-Becker, I ;
Molina-Holgado, F ;
Ramos, JA ;
Mechoulam, R ;
Fernández-Ruiz, J .
NEUROBIOLOGY OF DISEASE, 2005, 19 (1-2) :96-107
[2]   Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug [J].
Zuardi, AW ;
Crippa, JAS ;
Hallak, JEC ;
Moreira, FA ;
Guimaraes, FS .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (04) :421-429
[3]   EFFECTS OF CANNABIDIOL IN ANIMAL-MODELS PREDICTIVE OF ANTIPSYCHOTIC ACTIVITY [J].
ZUARDI, AW ;
RODRIGUES, JA ;
CUNHA, JM .
PSYCHOPHARMACOLOGY, 1991, 104 (02) :260-264